Alterations in the kynurenine pathway and excitatory amino acid transporter-2 in depression with and without psychosis: Evidence of a potential astrocyte pathology

The kynurenine pathway in major depression: What we know and where to next

(2021) Samara J. Brown et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Single-cell mass cytometry of microglia in major depressive disorder reveals a non-inflammatory phenotype with increased homeostatic marker expression

(2020) Chotima Böttcher et al.   Translational Psychiatry

The ‘Yin’ and the ‘Yang’ of the kynurenine pathway

(2019) Pascal Barone   BEHAVIOURAL PHARMACOLOGY

Prefrontal alterations in GABAergic and glutamatergic gene expression in relation to depression and suicide

(2018) J. Zhao et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Kynurenine pathway in depression: A systematic review and meta-analysis

(2018) Kamiyu Ogyu et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Role of Kynurenine Pathway and its Metabolites in Mood Disorders: A Systematic Review and Meta-Analysis of Clinical Studies

(2018) Danilo Arnone et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2018) Spencer L James et al.   LANCET

Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder

(2018) Michael J. Gandal et al.   SCIENCE

Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals

(2016) Sarah M. Clark et al.   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

Proteomic Enrichment Analysis of Psychotic and Affective Disorders Reveals Common Signatures in Presynaptic Glutamatergic Signaling and Energy Metabolism

(2015) Michael G. Gottschalk et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Diverse subtypes of astrocytes and their development during corticogenesis

(2015) Hidenori Tabata   Frontiers in Neuroscience

Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses?

(2014) Mandy Busse et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

The role of NMDA receptors in the pathophysiology and treatment of mood disorders

(2014) Mehdi Ghasemi et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Tryptophan-Catabolizing Enzymes – Party of Three

(2014) Helen J. Ball et al.   Frontiers in Immunology

From Pathophysiology to Novel Antidepressant Drugs: Glial Contributions to the Pathology and Treatment of Mood Disorders

(2013) Gerard Sanacora et al.   BIOLOGICAL PSYCHIATRY

Astrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue

(2013) Grazyna Rajkowska et al.   CURRENT DRUG TARGETS

Kynurenines: from the perspective of major psychiatric disorders

(2012) Aye M. Myint   FEBS Journal

Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients

(2012) D Martins-de-Souza et al.   Translational Psychiatry

Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?

(2011) Johann Steiner et al.   Journal of Neuroinflammation

Grand challenges in global mental health

(2011) Pamela Y. Collins et al.   NATURE

Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine

(2011) Kathleen S. Alexander et al.   PSYCHOPHARMACOLOGY

Selection of Reference Gene Expression in a Schizophrenia Brain Cohort

(2010) Cynthia Shannon Weickert et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Glial and glutamatergic markers in depression, alcoholism, and their comorbidity

(2010) José Javier Miguel-Hidalgo et al.   JOURNAL OF AFFECTIVE DISORDERS

Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry

(2010) Å. Konradsson-Geuken et al.   NEUROSCIENCE

The Astrocyte-Derived α7 Nicotinic Receptor Antagonist Kynurenic Acid Controls Extracellular Glutamate Levels in the Prefrontal Cortex

(2009) Hui-Qiu Wu et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder

(2008) Christine L. Miller et al.   NEUROCHEMISTRY INTERNATIONAL